Results 141 to 150 of about 152,046 (196)
Cancer, 2009 AbstractBACKGROUND:This retrospective comparison evaluated survival in 2 well‐matched cohorts of patients with neoplastic meningitis (NM) presenting with or without positive cerebrospinal fluid (CSF) cytology.METHODS:Two patient cohorts were studied: 42 individuals with (Group A) and 42 without (Group B) positive CSF cytology.
Marc C Chamberlain, Sandra K Johnston
exaly +4 more sources
Chronic and Subacute Meningitis: Differentiating Neoplastic From Non-Neoplastic Etiologies
Neurohospitalist, The, 2018 Background and Purpose: Although incidence rates vary, infectious, autoimmune, and neoplastic diseases can all cause chronic and subacute meningitis (CSM).
Mariano Marrodan, Mauricio F Farez
exaly +2 more sources
Seminars in Neurology, 2004 Neoplastic meningitis (NM) is a common problem in neuro-oncology occurring in approximately 5% of all patients with cancer, and is the third most common site of CNS metastases. NM is a disease affecting the entire neuraxis, and therefore clinical manifestations are pleomorphic affecting the spine, cranial nerves, and cerebral hemispheres.
Marc C Chamberlain
exaly +8 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Treatment of Neoplastic Meningitis
Expert Opinion on Pharmacotherapy, 2004Neoplastic meningitis (NM) is a debilitating complication of cancer that occurs when tumour cells infiltrate the leptomeninges. Treatment often includes direct installation of chemotherapy into the cerebrospinal fluid either by lumbar puncture or the use of a ventricular reservoir, radiation therapy, systemic chemotherapy or a combination of these ...
Terri Armstrong, Mark R Gilbert
exaly +3 more sources
Chemotherapy in Neoplastic Meningitis
Critical Reviews in Oncology/Hematology, 2006Neoplastic meningitis (NM) is the result of the diffuse or multifocal localization of cancer cells in the cerebral spinal fluid (CSF). NM is more often a late complication of solid tumor or lymphoproliferative malignancies. At present, the goal of therapeutic strategies is palliative and the evaluation of high or low risk is important in identifying ...
Alessandra Fabi, Andrea Pace
exaly +3 more sources
Current Treatment Options in Oncology, 2001
Neoplastic meningitis is recognized clinically in 4% to 7% of patients with extraneural cancer, but it remains dramatically under-diagnosed. The frequency of neoplastic meningitis is increasing because of heightened clinical suspicion, improved neuroimaging techniques, and longer survival in patients with extraneural cancer Longer survival allows ...
L, Kim, M J, Glantz
openaire +3 more sources
Neoplastic meningitis is recognized clinically in 4% to 7% of patients with extraneural cancer, but it remains dramatically under-diagnosed. The frequency of neoplastic meningitis is increasing because of heightened clinical suspicion, improved neuroimaging techniques, and longer survival in patients with extraneural cancer Longer survival allows ...
L, Kim, M J, Glantz
openaire +3 more sources
Journal of neurosurgery, 2011
Neoplastic meningitis(NM)is a common problem in neuro-oncology. Notwithstanding its frequent focal signs and symptoms, NM is a disease affecting the entire neuraxis, and therefore its staging and treatment must include all cerebrospinal fluid (CSF)compartments.
Andrew, Shaw, E Antonio, Chiocca
+7 more sources
Neoplastic meningitis(NM)is a common problem in neuro-oncology. Notwithstanding its frequent focal signs and symptoms, NM is a disease affecting the entire neuraxis, and therefore its staging and treatment must include all cerebrospinal fluid (CSF)compartments.
Andrew, Shaw, E Antonio, Chiocca
+7 more sources
The Journal of Supportive Oncology, 2012
Neoplastic meningitis occurs in approximately 5%-10% of all patients with cancer, and aggressive supportive measures are a critical component of comprehensive care. A literature review of the current diagnostic methods, randomized controlled trials, and available treatments was undertaken; and a comprehensive discussion of best-practice supportive care
Alixis, Van Horn, Marc C, Chamberlain
openaire +2 more sources
Neoplastic meningitis occurs in approximately 5%-10% of all patients with cancer, and aggressive supportive measures are a critical component of comprehensive care. A literature review of the current diagnostic methods, randomized controlled trials, and available treatments was undertaken; and a comprehensive discussion of best-practice supportive care
Alixis, Van Horn, Marc C, Chamberlain
openaire +2 more sources
Current Neurology and Neuroscience Reports, 2002
Neoplastic meningitis (NM) is a common problem in neuro-oncology, occurring in approximately 5% of all patients with cancer. Notwithstanding frequent focal signs and symptoms, NM is a disease that affects the entire neuraxis; therefore, staging and treatment need to encompass all cerebrospinal fluid (CSF) compartments.
Ana, Aparicio, Marc C, Chamberlain
openaire +2 more sources
Neoplastic meningitis (NM) is a common problem in neuro-oncology, occurring in approximately 5% of all patients with cancer. Notwithstanding frequent focal signs and symptoms, NM is a disease that affects the entire neuraxis; therefore, staging and treatment need to encompass all cerebrospinal fluid (CSF) compartments.
Ana, Aparicio, Marc C, Chamberlain
openaire +2 more sources